To the Editor In their article on breast cancer risk in BRCA1 mutation carriers who were given hormone replacement therapy postovariectomy, the authors use the word "progesterone" throughout without explanation or qualification. The corresponding author affirmed that most of these women received various progestins, not progesterone.
https://ift.tt/2R2LoPt
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
http://bit.ly/2SylJiJ
-
Publication date: June 2018 Source: Acta Biomaterialia, Volume 73 https://ift.tt/2kBbISt
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου